Author:
Misra Shivani,Owen Katharine R.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference84 articles.
1. De Franco E, Flanagan SE, Houghton JAL, Allen HL, Mackay DJG, Temple IK, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet Elsevier. 2015;386(9997):957–63.
2. • Shields BM, Shepherd M, Hudson M, McDonald TJ, Colclough K, Peters J, et al. Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care. 2017;40(8):1017–25. This article highlights the benefits of the biomarker approach to MODY testing over clinical and probability calculator approaches.
3. Johansson BB, Irgens HU, Molnes J, Sztromwasser P, Aukrust I, Juliusson PB, et al. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. Diabetologia. Germany. 2017;60(4):625–35.
4. Misra S, Hattersley AT. Chapter 18 monogenic causes of diabetes. In: Holt R, Cockram C, Flyvbjerg A, Godlstein B, editors. Textbook of diabetes, 5th edition. 5th ed. Wiley; 2017. p. 243.
5. Diabetes genes: targeted next generation sequencing: analysis of 61 monogenic diabetes genes. Available at
https://www.diabetesgenes.org/tests-for-diabetes-subtypes/targeted-next-generation-sequencing-analysis-of-45-monogenic-diabetes-genes
. Accessed September 26, 2018.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献